Unique ID issued by UMIN | UMIN000007101 |
---|---|
Receipt number | R000008364 |
Scientific Title | Antihypertensive Efficacy of the Losartan/Hydrochlorothiazide Combination and its Effect on Plasma B-Type Natriuretic Peptide in Hypertensive Patients Uncontrolled by Angiotensin 2 Type 1 Receptor Antagonist Based Therapy |
Date of disclosure of the study information | 2012/01/19 |
Last modified on | 2012/01/24 18:03:34 |
Antihypertensive Efficacy of the Losartan/Hydrochlorothiazide
Combination and its Effect on Plasma
B-Type Natriuretic Peptide in Hypertensive Patients Uncontrolled by Angiotensin 2 Type 1 Receptor Antagonist Based Therapy
Southern Heart Conference Clinical research
Antihypertensive Efficacy of the Losartan/Hydrochlorothiazide
Combination and its Effect on Plasma
B-Type Natriuretic Peptide in Hypertensive Patients Uncontrolled by Angiotensin 2 Type 1 Receptor Antagonist Based Therapy
Southern Heart Conference Clinical research
Japan |
Hypertension
Medicine in general | Cardiology |
Others
NO
As a part of intensive medical treatment based on the guideline for treatment of hypertension, a combination drug of an ARB (losartan 50 mg) and a thiazide diuretic (HCTZ 12.5 mg) is to be administered in patients with uncontrolled hypertension, and its antihypertensive effect, B-Type Natriuretic Peptide and safety are to be examined.
Safety,Efficacy
Exploratory
Pragmatic
Phase IV
Change and % change in BNP after 12 months of treatment
Change and % change in blood pressure after 1,2,3,6,9,12,18,24,30 and 36 months of treatment
Change and % change in Uric acid, HbA1c, HDL-C, BNP (excluding values at 12 months), Echocardiography, Electrocardiogram after 3,12,24,30 and 36 months of treatment
Observational
20 | years-old | <= |
80 | years-old | > |
Male
1) Patients with essential hypertension, who have been previously treated with antihypertensive drugs including ARB for more than 3 months, however, the target blood pressure defined by the guideline for treatment of hypertension has not been achieved
2) Patiens aged 20 to 79 years at the time of the first visit
3) Outpatients
4) Patients who have given written informed consent on use of theie data for the study
1) Patients with secondary hypertension
2) Patients with cardiac insufficiency (more than NYHA grade II)
3) Patients under treatment with thiazide diuretic
4) Pregnant patients including one trying to conceive pregnancy during the planned study period
5) Patients with severe liver dysfunction
6) Patients with renal failure (serum creatinine ≥2.0 mg/dL)
7) Patients with a history of hypersensitivity to ingredients of losartan and hydrochlorothiazide
8) Patients with a history of hypersensitivity to thiazide or thiazide-like diuretics
9) Patients who are considered not eligible for the study by the attending doctor due to medical reasons
200
1st name | |
Middle name | |
Last name | Tetsuji Inou,Hiroshi Meno |
Fukuoka Red Cross Hospital
Department of Cardiology and Internal Medicine
3-1-1 Ohkusu, Minami-ku Fukuoka
092-521-1211
1st name | |
Middle name | |
Last name | Hiroshi Meno |
Southern Heart Conference secretariat
Southern Heart Conference secretariat
092-521-1211
Southern Heart Conference
Japan Heart Foundation
Non profit foundation
NO
2012 | Year | 01 | Month | 19 | Day |
Published
Completed
2007 | Year | 10 | Month | 01 | Day |
2008 | Year | 02 | Month | 01 | Day |
2011 | Year | 12 | Month | 01 | Day |
Prospective observational study
2012 | Year | 01 | Month | 19 | Day |
2012 | Year | 01 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008364